# Bioventures Investors: portfolio, investments and team > Bioventures Investors is a private equity based in United States. 21 investments on record, latest Nov 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/bioventures-investors (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Bioventures Investors Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Quiet New fund $205M, Dec 2022 Private equity Seed Series A Series B Health Medical Device Diagnostics Follow Bioventures Investors and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fbioventures-investors) Cheques on record **0%** of best year **0** **cheques in 12 months**, 21 on record Since the last cheque **2546** days **00** hrs **00** min **00** sec Median round **$32M** Cheque size, as they say **$5.0M – $25M** Rounds led **0 of 21** Sole investor **3 rounds** Exits **6 from the portfolio** Mostly in **United States, 100%** Pitch Bioventures Investors ## Bioventures Investors highlights - 01 21 rounds on record - 02 Mostly Series B and Series C: 52% of its rounds - 03 Sole investor in 3 rounds, median $3.4M - 04 6 exits from the portfolio ## What they do > WE INVEST IN EMERGING & GROWTH STAGE MEDTECH COMPANIES From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** $5.0M – $25M as they say - **Stages:** Seed Series A Series B Growth - **Sectors:** Health Medical Device Diagnostics - **Based in:** Wellesley, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **21 appearances** - **2019** 2 rounds - **Nov** **[SonoMotion](https://millionrounds.com/company/sonomotion)** Series B · US · FinSMEs **$10M** With 2 others - **Oct** **[Endotronix](https://millionrounds.com/company/endotronix)** Series D · US · Massdevice **$70M** With 8 others - **2016** 1 round - **Jul** **[Endotronix](https://millionrounds.com/company/endotronix)** Series C · US · FinSMEs **$32M** With 2 others - **2010** 1 round - **Sept** **[Cylene Pharmaceuticals](https://millionrounds.com/company/cylene-pharmaceuticals)** Series D · US · socaltech.com **$12M** With 6 others - **2009** 1 round - **Mar** **[Claros Diagnostics](https://millionrounds.com/company/claros-diagnostics)** Series B · US · pehub.com **$4.0M** With 3 others - **2008** 2 rounds - **Oct** **[Biolex Therapeutics](https://millionrounds.com/company/biolex-therapeutics)** Series D · US · mitsuiventures.com **$60M** With 10 others - **Mar** **[Hydra Biosciences](https://millionrounds.com/company/hydra-biosciences)** Series C · US **$34M** With 5 others - **2007** 7 rounds - **Dec** **[Verax Biomedical](https://millionrounds.com/company/verax-biomedical)** Series E · US **$2.5M** With 2 others - **Sept** **[Cardiosolutions](https://millionrounds.com/company/cardiosolutions)** Series A · US **$7.0M** Sole investor - **Jun** **[Verax Biomedical](https://millionrounds.com/company/verax-biomedical)** Venture · US **$3.0M** Sole investor - **Jun** **[Sciona](https://millionrounds.com/company/sciona)** Venture · US **$3.4M** Sole investor - **Apr** **[Spirus Medical](https://millionrounds.com/company/spirus-medical)** Series B · US **$8.5M** With 2 others - **Jan** **[Cylene Pharmaceuticals](https://millionrounds.com/company/cylene-pharmaceuticals)** Series C · US · rctech.com **$44M** With 7 others - **Jan** **[Claros Diagnostics](https://millionrounds.com/company/claros-diagnostics)** Series A · US **$7.8M** With 3 others - **2006** 1 round - **Apr** **[Sciona](https://millionrounds.com/company/sciona)** Series C · US **$9.9M** With 4 others - **2005** 1 round - **May** **[Cylene Pharmaceuticals](https://millionrounds.com/company/cylene-pharmaceuticals)** Series B · US **$26M** With 5 others - **2004** 2 rounds - **Jan** **[Enanta Pharmaceuticals](https://millionrounds.com/company/enanta-pharmaceuticals)** Venture · US **$12M** With 7 others - **Jan** **[Hydra Biosciences](https://millionrounds.com/company/hydra-biosciences)** Series B · US **$19M** With 7 others - **2003** 1 round - **Sept** **[Angiolink Corporation](https://millionrounds.com/company/angiolink-corporation)** Series B **$14M** With 2 others - **2002** 1 round - **Dec** **[Pintex Pharmaceuticals](https://millionrounds.com/company/pintex-pharmaceuticals)** Series B · US **$7.3M** With 3 others - **2000** 1 round - **Aug** **[Phase Forward](https://millionrounds.com/company/phase-forward)** Venture · US **$25M** With 7 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **6 named** JL **James Lousararian** Managing Director of Bioventures Investors IV Management LLC i Form ADV JT **Jeffrey Thomas Barnes** Managing Director of Bioventures Investors IV Management LLC i Form ADV JP **Jonathan Paull Gertler** Managing Director of Bioventures Medtech Growth Capital Management LLC i Form ADV ME **Marc Evan Goldberg** Managing Director of the General Partner i Filing they signed PL **Peter Lawrence Feinstein** Managing Director of Bioventures Investors II, LLC i Form ADV WG **Walter Gilbert** Managing Director of Bioventures Investors II, LLC i Form ADV We also hold **11** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$303M** gross assets of its funds Oct 2026 **Exempt** reporting adviser venture or small private funds - **Legal name:** Bioventures II Management Corporation - **SEC number:** CRD 161520 ## What they claim to have backed From their own portfolio page (on their website) **3** of 7 we have independently watched raise [CareSignal](https://millionrounds.com/company/caresignal)[Sono Motion](https://millionrounds.com/company/sonomotion)[Verax Biomedical](https://millionrounds.com/company/verax-biomedical) Brainbox Solutions CoNextions Optivio UID Identification Solutions Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **6 in all** **[Enanta Pharmaceuticals](https://millionrounds.com/company/enanta-pharmaceuticals)** Listed **$56M** Mar 2013 **[Claros Diagnostics](https://millionrounds.com/company/claros-diagnostics)** Bought by [OPKO Health](https://millionrounds.com/fund/opko-health) **Undisclosed** Oct 2011 **[Spirus Medical](https://millionrounds.com/company/spirus-medical)** Bought by Olympus Corporation **Undisclosed** Jul 2011 **[Phase Forward](https://millionrounds.com/company/phase-forward)** Bought by [Oracle Corporation](https://millionrounds.com/fund/oracle) **$685M** Apr 2010 **[Pintex Pharmaceuticals](https://millionrounds.com/company/pintex-pharmaceuticals)** Bought by Vernalis **Undisclosed** Apr 2005 **[Angiolink Corporation](https://millionrounds.com/company/angiolink-corporation)** Bought by [Medtronic](https://millionrounds.com/fund/medtronic) **Undisclosed** Sept 2003 An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$205M** raised in Dec 2022 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$32M** the round, not its cheque Alone, median **$3.4M** Led 0 of 21 rounds **0%** - **Said size:** $5.0M – $25M - **Sole investor:** 3 rounds - **Last cheque:** Nov 2019 - **Exits:** 6 from the portfolio Rounds by stage said on their site - Series B said *7* - Series C *4* - Venture *4* - Series D *3* - Series A said *2* - Series E *1* - Seed said *-* Cheques by year Led Joined 2000 2019 Often in the room with - [Oxford Bioscience Partners](https://millionrounds.com/fund/oxford-bioscience-partners) 3 - [Abingworth](https://millionrounds.com/fund/abingworth) 2 - [Accelerated Technologies Partners](https://millionrounds.com/fund/accelerated-technologies-partners) 2 - [Advanced Technology Ventures](https://millionrounds.com/fund/advanced-technology-ventures) 2 - [Commons Capital](https://millionrounds.com/fund/commons-capital) 2 - [HBM BioVentures](https://millionrounds.com/fund/hbm-bioventures) 2 **Pitching Bioventures Investors?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Bioventures Investors. A count of rooms they were both in, not a relationship either has claimed. [**Oxford Bioscience Partners** Growth equity **3** rounds together](https://millionrounds.com/fund/oxford-bioscience-partners)[**Abingworth** VC firm **2** rounds together](https://millionrounds.com/fund/abingworth)[**Accelerated Technologies Partners** VC firm **2** rounds together](https://millionrounds.com/fund/accelerated-technologies-partners)[**Advanced Technology Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/advanced-technology-ventures)[**Commons Capital** VC firm **2** rounds together](https://millionrounds.com/fund/commons-capital)[**HBM BioVentures** Growth equity **2** rounds together](https://millionrounds.com/fund/hbm-bioventures)[**Lilly Ventures** Corporate VC **2** rounds together](https://millionrounds.com/fund/lilly-ventures)[**Lumira Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/lumira-ventures)[**Mitsui Global Investment** Corporate VC **2** rounds together](https://millionrounds.com/fund/mitsui-and-co-global-investment-ltd)[**New Enterprise Associates** VC firm **2** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Polaris Partners** VC firm **2** rounds together](https://millionrounds.com/fund/polaris-partners) ## Recently backed The latest companies Bioventures Investors put money into. [**SonoMotion** $10M · Nov 2019](https://millionrounds.com/company/sonomotion)[**Endotronix** $70M · Oct 2019](https://millionrounds.com/company/endotronix) ## Quick answers about Bioventures Investors ### What does Bioventures Investors invest in? Bioventures Investors invests most often at Series B and Series C (52% of the rounds on record), in sectors such as Health, Medical Device and Diagnostics. ### How active is Bioventures Investors? 21 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2019. ### What has Bioventures Investors invested in recently? Its most recent investments on record: SonoMotion (Series B, Nov 2019) and Endotronix (Series D, Oct 2019). ### How big are Bioventures Investors's cheques? The median round it joins is $32M. It says it writes cheques of $5.0M to $25M. ### Does Bioventures Investors lead rounds? Rarely, if at all: none of its 21 investments on record names it as the lead. ### Where does Bioventures Investors invest? Most of the companies it backs are in the United States (100%). ### Is Bioventures Investors investing now? No investments in the last 12 months; the latest was in Nov 2019. ### Who does Bioventures Investors invest alongside? Most often Oxford Bioscience Partners (3 rounds together), Abingworth (2 rounds together) and Accelerated Technologies Partners (2 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=bioventures-investors) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=bioventures-investors)